JAMES LABUS: Open Payments
NPI 1992732457 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$532 in 22 payments from 8 companies in 2025. Trend: 2023 $330 · 2024 $394 · 2025 $532
Food & beverage: $532
| Company | Payments | Amount |
|---|---|---|
| Averitas Pharma Inc. | 5 | $138 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $110 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $97 |
| Boston Scientific Corporation | 3 | $76 |
| Valinor Pharma, LLC | 3 | $50 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| Globus Medical, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $17 |
Products named: QUTENZA, JOURNAVX, RELISTOR, MOVANTIK, WaveWriter Alpha Prime 16, General - Pain Management, Belbuca, Senza.
Industry payments across GA — which companies pay providers there.
